Magnova 250 mg/31.25 mg Injection 1*1

Magnova 250 mg/31.25 mg Injection is a combination medicine containing two powerful antibiotics. It is recommended for the treatment of various bacterial infections by stopping the growth and spread of harmful microorganisms inside the body.

This injection should only be administered under the care of a medical professional. It is important to complete the full treatment course, even if symptoms improve earlier, to ensure complete recovery and to prevent the bacteria from becoming resistant.

Some people may experience mild side effects such as nausea, vomiting, loose motions, skin rash, or reactions at the injection site like redness, pain, or swelling. These generally improve with time, but if they worsen or an allergic reaction occurs (such as itching, swelling, breathing difficulty, or severe rashes), medical attention is necessary.

Before starting the treatment, let your doctor know about any ongoing medications or existing health conditions. Pregnant or breastfeeding women should only take this medicine after medical consultation. Drinking alcohol is not advisable during treatment since it may increase drowsiness. The injection usually does not interfere with daily activities, but driving should be avoided if dizziness or blurred vision occurs after use.

Magnova Injection is prescribed for bacterial infections. It contains two active substances, Cefepime and Tazobactam. Cefepime is an antibiotic that blocks the formation of the bacterial cell wall, which is crucial for bacteria to survive. Tazobactam works by blocking certain enzymes made by bacteria that reduce the effect of antibiotics. Together, these medicines make the treatment more effective and reduce the chances of antibiotic resistance.

Most side effects are temporary and improve as the body adjusts. Common ones include diarrhea, skin rashes, elevation in liver enzymes, injection site irritation, or a temporary rise in certain blood cells. Rarely, it may cause a positive Coombs test.

This medicine is given only by a doctor or nurse and should not be self-administered.

Safety considerations:
Alcohol should be avoided while taking this medicine. It is considered safe for use during pregnancy if prescribed and can generally be taken during breastfeeding as only a negligible amount passes into breast milk. Magnova may cause short-term blurred vision, so driving immediately after the injection should be avoided. Patients with kidney disease may require dose adjustments, while those with liver problems usually do not need changes but should still consult their doctor.

If a scheduled dose is missed, it is important to seek advice from the doctor on the next step instead of taking it without guidance.